During the past decade, Apollo Gleneagles Hospitals Kolkata conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 12 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 10 clinical trials were completed. i.e. 111.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Apollo Gleneagles Hospitals Kolkata" #1 sponsor was "Eli Lilly and Company" with 9 trials, followed by "Johnson & Johnson Private Limited" with 3 trials sponsored, "Boston Scientific Corporation" with 2 trials sponsored, "Galapagos NV" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Apollo Gleneagles Hospitals Kolkata" #1 collaborator was "Apollo Gleneagles Hospitals, Kolkata" with 2 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "American Society for Gastrointestinal Endoscopy" with 1 trials as a collaborator, "Apollo Hospitals Enterprise Limited" with 1 trials as a collaborator and "Asian Clinical Trials" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Apollo Gleneagles Hospitals Kolkata" are "Rheumatoid Arthritis" (3 trials), "Breast Cancer" (2 trials), "Type 2 Diabetes" (2 trials), "Arthritis, Psoriatic" (1 trials) and "Biliary Obstruction Due to Common Bile Duct Stone" (1 trials). Many other conditions were trialed in "Apollo Gleneagles Hospitals Kolkata" in a lesser frequency.

Most popular intervention types in "Apollo Gleneagles Hospitals Kolkata" are "Drug" (25 trials), "Device" (4 trials), "Other" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Abemaciclib" (2 trials), "Dulaglutide" (2 trials), "Filgotinib" (2 trials) and "Galcanezumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Apollo Gleneagles Hospitals Kolkata" are 29 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Apollo Gleneagles Hospitals Kolkata". undefined are not yet recruiting, 8 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Apollo Gleneagles Hospitals Kolkata, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Apollo Gleneagles Hospitals Kolkata, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 4 trials that are defined as “Not Applicable".